Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review

Authors: Coelingh Bennink, Herjan J.T. ^{a, ∗}, Egberts, Jan F.M. ^b, Debruyne, Frans M.J. ^c

Source: In Heliyon December 2022 8(12)

Estetrol Prevents Hot Flushes and Improves Quality of Life in Patients with Advanced Prostate Cancer Treated with Androgen Deprivation Therapy: The PCombi Study

Authors: Zimmerman, Yvette, Frydenberg, Mark, van Poppel, Hendrik, van Moorselaar, R. Jeroen A., Roos, Erik P.M., Somford, Diederik M., Roeleveld, Ton A., de Haan, Tjard D., van Melick, Harm H.E., Reisman, Yacov, Krijgh, Jan, Debruyne, Frans M.J., Coelingh Bennink, Herjan J.T.

Source: In European Urology Open Science November 2022 45:59-67

Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)

Authors: Coelingh Bennink, Herjan J.T. ^⁎, van Moorselaar, Jeroen A., Crawford, E. David, Roos, Erik P.M., Somford, Diederik M., Roeleveld, Ton A., de Haan, Tjard D., van Melick, Harm H.E., Reisman, Yacov, Zimmerman, Yvette, van Osta, Gonnie, Krijgh, Jan, Shore, Neal D., Saad, Fred, Schally, Andrew V., Debruyne, Frans M.J.

Source: In European Urology Open Science June 2021 28:52-61

Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy

Authors: Coelingh Bennink, Herjan J.T., Foidart, Jean-Michel, Debruyne, Frans M.J.

Source: European urology. 80(4):523-525

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138680741.0x000001&indx=1&recIds=ETOCvdc_100138680741.0x000001

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)

Authors: Maggi, M., Behre, H.M., Meuleman, E., Dohle, G., Arver, S., Wu, F., Porst, H., Jones, T.H., Quinton, R., Lenzi, A., Bouloux, P.-M., Morales, A.M., Hackett, G., Stroberg, P., Maggio, M., Cruz, N., Balercia, G., Yassin, A., Reisman, C., Bassas, L., Pescatori, E., Salamanca, J.I. Martinez, Otero, J. Romero, Jockenhoevel, F., Debruyne, F., Rosen, Raymond C., Wu, Frederick, Behre, Hermann M., Porst, Hartmut, Meuleman, Eric J.H., Maggi, Mario, Romero-Otero, Javier, Martinez-Salamanca, Juan I., Jones, Thomas Hugh, Debruyne, Frans M.J., Kurth, Karl-Heinz, Hackett, Geoff I., Quinton, Richard, Stroberg, Peter, Reisman, Yacov, Pescatori, Edoardo S., Morales, Antonio, Bassas, Lluis, Cruz, Natalio, Cunningham, Glenn R., Wheaton, Olivia A.

Source: In The Journal of Sexual Medicine September 2017 14(9):1104-1115

Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)

Authors: Rosen, Raymond C., Wu, Frederick, Behre, Hermann M., Porst, Hartmut, Meuleman, Eric J.H., Maggi, Mario, Romero-Otero, Javier, Martinez-Salamanca, Juan I., Jones, Thomas Hugh, Debruyne, Frans M.J., Kurth, Karl-Heinz, Hackett, Geoff I., Quinton, Richard, Stroberg, Peter, Reisman, Yacov, Pescatori, Edoardo S., Morales, Antonio, Bassas, Lluis, Cruz, Natalio, Cunningham, Glenn R., Wheaton, Olivia A.

Source: Journal of sexual medicine. 14(9):1104-1115

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100063570269.0x000001&indx=1&recIds=ETOCvdc_100063570269.0x000001

Festschrift essay to celebrate Dr. Michael Droller.

Authors: Debruyne, Frans M.J.¹ (AUTHOR) f.debruyne@andros.nl

Source: Urologic Oncology. Feb2025, Vol. 43 Issue 2, p99-100. 2p.

Reply to Bexultan Kazybay and Yingqiu Xie's Letter to the Editor re: Herjan J.T. Coelingh Bennink, Jean-Michel Foidart, Frans M.J. Debruyne. Treatment of Serious COVID-19 with Testosterone Suppression and High-dose Estrogen Therapy. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.06.024

Authors: Coelingh Bennink, Herjan J.T., Foidart, Jean-Michel, Debruyne, Frans M.J.

Source: European urology. 80(5):e117-e118

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165182129.0x000001&indx=1&recIds=ETOCvdc_100165182129.0x000001

Time to Onset of Action of Vardenafil: A Retrospective Analysis of the Pivotal Trials for the Orodispersible and Film‐Coated Tablet Formulations

Authors: Debruyne, Frans M.J. ^*, Gittelman, Marc, Sperling, Herbert, Börner, Matthias, Beneke, Manfred

Source: In The Journal of Sexual Medicine October 2011 8(10):2912-2923

Bladder Cancer: Management and Future Directions

Authors: Evans, Christopher P., Debruyne, Frans M.J., Payne, Heather, Solsona, Eduardo, Teillac, Pierre, Tubaro, Andrea

Source: In European Urology Supplements 2007 6(3):365-373

The Continuing Role of PSA in the Detection and Management of Prostate Cancer

Authors: Miller, Kurt, Abrahamsson, Per-Anders, Akakura, Koichiro, Debruyne, Frans M.J., Evans, Christopher P., Klotz, Laurence

Source: In European Urology Supplements 2007 6(3):327-333

Implant-Driven Tibial Nerve Stimulation in the Treatment of Refractory Overactive Bladder Syndrome: 12-Month Follow-up

Authors: van der Pal, Floor ^*, van Balken, Michael R., Heesakkers, John P.F.A. ^{*, **}, Debruyne, Frans M.J. ^*, Bemelmans, Bart L.H.

Source: In Neuromodulation: Technology at the Neural Interface April 2006 9(2):163-171

Expert Opinion on Optimal Testosterone Control in Prostate Cancer

Authors: Zlotta, Alex, Debruyne, Frans M.J. ^*

Source: In European Urology Supplements 2005 4(8):37-41

Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.

Authors: Debruyne, Frans M.J.¹, Behre, Hermann M.², Roehrborn, Claus G.³, Maggi, Mario⁴, Wu, Frederick C.W.⁵, Schröder, Fritz H.⁶, Jones, Thomas Hugh⁷, Porst, Hartmut⁸, Hackett, Geoffrey⁹, Wheaton, Olivia A.¹⁰, Martin‐Morales, Antonio¹¹, Meuleman, Eric¹², Cunningham, Glenn R.¹³, Divan, Hozefa A.¹⁰, Rosen, Raymond C.¹⁰ RRosen@neriscience.com, Dohle, G., Arver, S., Lenzi, A., Stroberg, P., Maggio, M.

Source: BJU International. Feb2017, Vol. 119 Issue 2, p216-224. 9p.

Subject Terms: *PROSTATE cancer risk factors, *HYPOGONADISM, *THERAPEUTIC use of testosterone, *URINARY organ diseases, *DIAGNOSIS, *PROSTATE cancer, *PROSTATE-specific antigen, *REPORTING of diseases, *THERAPEUTICS

Handling and Pathology Reporting of Circumcision and Penectomy Specimens

Authors: Mikuz, Gregor, Winstanley, Alison M., Schulman, Claude C., Debruyne, Frans M.J., Parkinson, Constance M.

Source: In European Urology 2004 46(4):434-439

Clinical and socioeconomic relevance of overactive bladder

Authors: Debruyne, Frans M.J., Heesakkers, John P.F.A.

Source: In Urology 2004 63(3) Supplement 1:42-44

Percutaneous Tibial Nerve Stimulation as Neuromodulative Treatment of Chronic Pelvic Pain

Authors: van Balken, Michael R, Vandoninck, Vera, Messelink, Bert J, Vergunst, Henk, Heesakkers, John P.F.A, Debruyne, Frans M.J, Bemelmans, Bart L.H

Source: In European Urology 2003 43(2):158-163

Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction

Authors: Vandoninck, Vera, van Balken, Michael R, Finazzi Agr, Enrico, Petta, Filomena, Micali, Francesco, Heesakkers, John P.F.A, Debruyne, Frans M.J, Kiemeney, Lambertus A.L.M, Bemelmans, Bart L.H

Source: In Urology 2003 61(3):567-572

Long-Term Results of Ileum Interposition for Ureteral Obstruction

Authors: Verduyckt, Frank J.H, Heesakkers, John P.F.A, Debruyne, Frans M.J

Source: In European Urology 2002 42(2):181-187

Baseline Prostatic Specific Antigen Does Not Predict The Outcome Of High Energy Transurethral Microwave Thermotherapy

Authors: Laguna, M. Pilar, Kiemeney, Lambertus A., Debruyne, Frans M.J., de la Rosette, Jean J.M.C.H.

Source: In The Journal of Urology 2002 167(4):1727-1730